NCT01083602 Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01082367 Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years Status COMPLETED Phase PHASE3
NCT01080768 Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension Status TERMINATED Phase PHASE2
NCT01080131 Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. Status COMPLETED Phase PHASE3
NCT01079143 Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT01077544 A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE1
NCT01077518 Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy Status TERMINATED Phase PHASE3
NCT01072266 A Dose-escalation Study in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01072175 Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212 Status COMPLETED Phase PHASE2
NCT01071928 Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma Status WITHDRAWN Phase PHASE2
NCT01071252 A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT01068613 Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE2
NCT01068483 Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT01066468 Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. Status TERMINATED Phase PHASE1
NCT01064791 Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients Status COMPLETED Phase PHASE2
NCT01064310 Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer Status COMPLETED Phase PHASE3